前往化源商城

(S)-10-Hydroxycamptothecin-d5

更新时间:2025-08-27 09:16:03

(S)-10-Hydroxycamptothecin-d5结构式
(S)-10-Hydroxycamptothecin-d5结构式
品牌特惠专场
常用名 (S)-10-Hydroxycamptothecin-d5 英文名 (S)-10-Hydroxycamptothecin-d5
CAS号 1330277-66-1 分子量 369.38
密度 N/A 沸点 N/A
分子式 C20H11D5N2O5 熔点 N/A
MSDS N/A 闪点 N/A

 (S)-10-Hydroxycamptothecin-d5用途


(S) -10-羟基喜树碱-d5(10-HCPT-d5)是氘标记的(S)-10-羟基喜树碱。(S) -10-羟基喜树碱(10-HCPT)是一种DNA拓扑异构酶I抑制剂。(S) -10-羟基喜树碱具有显著的凋亡诱导作用。(S) -10-羟基喜树碱有可能用于肝癌、胃癌、结肠癌和白血病研究[1][2][3][4]。

 (S)-10-Hydroxycamptothecin-d5名称

中文名 (S)-10-羟基喜树碱 d5
英文名 (S)-10-Hydroxycamptothecin-d5

 (S)-10-Hydroxycamptothecin-d5生物活性

描述 (S) -10-羟基喜树碱-d5(10-HCPT-d5)是氘标记的(S)-10-羟基喜树碱。(S) -10-羟基喜树碱(10-HCPT)是一种DNA拓扑异构酶I抑制剂。(S) -10-羟基喜树碱具有显著的凋亡诱导作用。(S) -10-羟基喜树碱有可能用于肝癌、胃癌、结肠癌和白血病研究[1][2][3][4]。
相关类别
体外研究 氢、碳和其他元素的稳定重同位素已被纳入药物分子,主要作为药物开发过程中定量的示踪剂。氘化因其可能影响药物的药代动力学和代谢特征而受到关注[1]。
参考文献

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

[2]. Min Liu, et al. Intracellular delivery of 10-hydroxycamptothecinwith targeted nanostructured lipid carriers againstmultidrug resistance. Journal of Drug Targeting.

[3]. Min Liu, et al. Intracellular delivery of 10-hydroxycamptothecin with targetednanostructured lipid carriers against multidrug resistance. J Drug Target, Early Online: 1–8

[4]. Yu P, et al. Synthesis and preliminary anticancer evaluation of 10-hydroxycamptothecin analogs. Biol Pharm Bull. 2012;35(8):1295-9.

[5]. Zhang XW, et al. Differentiation-inducing action of 10-hydroxycamptothecin on human hepatoma Hep G2 cells. Acta Pharmacol Sin. 2000 Apr;21(4):364-8.

[6]. Zhang XW, et al. Differential regulation of P53, c-Myc, Bcl-2, Bax and AFP protein expression, and caspase activity during 10-hydroxycamptothecin-induced apoptosis in Hep G2 cells. Anticancer Drugs. 2000 Oct;11(9):747-56.

[7]. Liu M, et al. Intracellular delivery of 10-hydroxycamptothecin with targeted nanostructured lipid carriers against multidrug resistance. J Drug Target. 2016;24(5):433-40.

 (S)-10-Hydroxycamptothecin-d5物理化学性质

分子式 C20H11D5N2O5
分子量 369.38
储存条件 -20°C,干燥,密封
本网页内容来自不同专业数据源,如对内容有疑义,欢迎联系service1@chemsrc.com。
品牌现货直购
推荐供应商:

暂无推荐供应商。我要出现这里

相关化合物: 更多...
(S)-10-hydroxycamptothecin
64439-81-2
(S)-10-Hydroxycamptothecin
19685-09-7
Chimmitecan
185425-25-6
(S)-9-(4-METHYL-1-PIPERAZINYL)METHYL-10-HYDROXYCAMPTOTHECIN
123948-91-4
(S)-10-isopropyl-1,2,3,11a-tetrahydro-5H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-5,11(10H)-dione
870677-83-1
S-[10-(4-methylquinolin-1-ium-1-yl)decyl] ethanethioate,iodide
448897-05-0
S-(10-(1,3-dioxoisoindolin-2-yl)decyl) ethanethioate
866219-37-6
(S)-10-amino-1,2,3-trimethoxy-7-methylamino-6,7-dihydro-5H-benzo[a]heptalen-9-one
6714-13-2
(S)-10-(Cyanomethyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
176760-98-8
methyl {1-[(6-fluoro-1H-indol-1-yl)acetyl]piperidin-4-yl}acetate
1282133-27-0
methyl (1-{[1-phenyl-5-(1H-pyrrol-1-yl)-1H-pyrazol-4-yl]carbonyl}piperidin-4-yl)acetate
1282099-12-0
1-(4-phenylpiperidin-1-yl)-2-[2-(1H-pyrrol-1-yl)-1,3-thiazol-4-yl]ethanone
1282129-96-7
N-[2-(5-chloro-1H-indol-3-yl)ethyl]-2-[3-(4-chlorophenyl)-6-oxopyridazin-1(6H)-yl]acetamide
1282130-05-5
2-{2-[4-(2-methoxyphenyl)piperazino]-2-oxoethyl}-5,6,7,8-tetrahydro-3(2H)-cinnolinone
1282126-37-7
N~1~-[2-(1-cyclohexenyl)ethyl]-2-(3-oxo-3,5,6,7,8,9-hexahydro-2H-cyclohepta[c]pyridazin-2-yl)acetamide
1282142-60-2
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-propyl-2-(1H-pyrrol-1-yl)-1,3-thiazole-5-carboxamide
1282142-63-5
(1-methyl-1H-indol-5-yl)(4-phenylpiperidin-1-yl)methanone
1282126-42-4
N-[(2Z)-4,5-dimethyl-1,3-thiazol-2(3H)-ylidene]-5,6,7,8-tetrahydro-4H-cyclohepta[d][1,2]oxazole-3-carboxamide
1282141-30-3
N-[2-(4-chloro-1H-indol-1-yl)ethyl]-2-furamide
1282141-36-9